rs765926471
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001010867.4(IBA57):c.286T>C(p.Tyr96His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000289 in 1,385,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y96C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001010867.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000289 AC: 4AN: 1385786Hom.: 0 Cov.: 33 AF XY: 0.00000146 AC XY: 1AN XY: 684042
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Multiple mitochondrial dysfunctions syndrome 3 Pathogenic:3
- -
- -
Through Trio-WES, compound heterozygous variants in the IBA57 gene were identified in the proband's testing data, which are [c.286T>C/p.Y96H] and [c.754G>A/p.G252S]. The c.286T>C variant is predicted to result in the substitution of the 96th amino acid in the protein from Tyrosine (Tyr) to Histidine (His), inherited from the father. The c.754G>A variant is predicted to result in the substitution of the 252nd amino acid in the protein from Glycine (Gly) to Serine (Ser), inherited from the mother. The c.286T>C variant has the rs number rs765926471 and is not recorded in general population carrier frequency databases such as the Thousand Genomes Project or gnomAD. According to the ACMG guidelines, this variant is classified as a pathogenic variant: PM2_Supporting + PM3_VeryStrong + PP1_Moderate + PP3, with the specific basis as follows: PM3_VeryStrong:The variant has been detected as a homozygous variant or in trans phase with pathogenic (P) or likely pathogenic (LP) variants, or in trans phase with variants of uncertain significance (VUS) in one or more patients with a phenotype correlation, achieving a PM3-Case_Score of ≥4.0 [PMID: 28671726, 32348839]. PP1_Moderate:The variant has been found to co-segregate at least twice in the self-check case database and literature reports for recessive diseases or at least four times for dominant diseases [PMID: 28671726]. PP3:Various bioinformatics computational methods predict that the variant has a deleterious effect on the gene/gene product or affects splicing to a level that meets the supportive threshold. In summary, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria applied. -
Multiple mitochondrial dysfunctions syndrome 3;C5568837:Hereditary spastic paraplegia 74 Pathogenic:1
PM2_Supporting+PP3_Moderate+PM3_VeryStrong -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at